NASDAQ : ALEC
Alector, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 2.21 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 327.65M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Alector, Inc. (ALEC) reported revenue of 13.86M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 13.86M | 21.05M | 100.56M | 97.06M | 133.62M | 207.09M |
| Cost of Revenue | 99.13M | 123.06M | 185.94M | 192.12M | 210.42M | 189.41M |
| Gross Profit | -85.27M | -102.02M | -85.38M | -95.05M | -76.80M | 17.68M |
| Selling, General & Admin | 38.30M | 51.06M | 57.41M | 56.69M | 61.03M | 55.04M |
| Operating Expenses | 38.30M | 51.06M | 57.41M | 56.69M | 61.03M | 55.04M |
| Operating Income | -123.56M | -153.09M | -142.79M | -151.74M | -137.83M | -37.36M |
| Interest & Investment Income | 6.67M | 6.67M | 11.70M | 11.24M | 6.62M | |
| Other Non Operating Income (Expenses) | -1.70M | 1.03M | ||||
| EBT Excluding Unusual Items | -118.60M | -146.42M | -131.09M | -140.50M | -131.22M | -36.33M |
| Gain (Loss) on Sale of Investments | 3.96M | 6.58M | 14.38M | 15.32M | 1.16M | |
| Asset Writedown | -2.92M | -2.92M | -2.21M | |||
| Pretax Income | -117.56M | -142.76M | -118.92M | -125.18M | -130.06M | -36.33M |
| Income Tax Expense | 298.00K | 168.00K | 128.00K | 5.21M | 3.25M | |
| Net Income | -117.85M | -142.93M | -119.05M | -130.39M | -133.31M | -36.33M |
| Net Income to Common | -117.85M | -142.93M | -119.05M | -130.39M | -133.31M | -36.33M |
| Shares Outstanding (Basic) | 108.51M | 103.00M | 96.59M | 83.73M | 82.47M | 80.42M |
| Shares Outstanding (Diluted) | 108.51M | 103.00M | 96.59M | 83.73M | 82.47M | 80.42M |
| EPS (Basic) | -1.09 | -1.39 | -1.23 | -1.56 | -1.62 | -0.45 |
| EPS (Diluted) | -1.09 | -1.39 | -1.23 | -1.56 | -1.62 | -0.45 |
| Free Cash Flow | -158.39M | -184.07M | -231.16M | -186.54M | -24.45M | 295.30M |
| Free Cash Flow Per Share | -1.46 | -1.79 | -2.39 | -2.23 | -0.30 | 3.67 |
| Gross Margin | -84.91% | -97.93% | -57.48% | 8.54% | ||
| Operating Margin | -891.32% | -727.42% | -142.00% | -156.33% | -103.16% | -18.04% |
| Profit Margin | -850.13% | -679.16% | -118.39% | -134.34% | -99.77% | -17.54% |
| Free Cash Flow Margin | -1,142.55% | -874.66% | -229.88% | -192.19% | -18.30% | 142.60% |
| EBITDA | -119.03M | -147.37M | -137.38M | -146.01M | -132.12M | -31.03M |
| EBITDA Margin | -136.62% | -150.44% | -98.88% | -14.99% | ||
| D&A For EBITDA | 4.54M | 5.72M | 5.41M | 5.72M | 5.71M | 6.33M |
| EBIT | -123.56M | -153.09M | -142.79M | -151.74M | -137.83M | -37.36M |
| EBIT Margin | -142.00% | -156.33% | -103.16% | -18.04% |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 59.91M | 65.80M | 33.02M | 74.56M | 154.32M | 329.15M |
| Short-Term Investments | 112.88M | 190.22M | 380.38M | 474.31M | 558.53M | 406.10M |
| Cash & Short-Term Investments | 172.80M | 256.02M | 413.40M | 548.86M | 712.85M | 735.25M |
| Other Receivables | 2.59M | 7.39M | ||||
| Receivables | 2.59M | 7.39M | ||||
| Prepaid Expenses | 7.29M | 10.43M | 11.42M | 16.95M | 11.00M | 7.07M |
| Total Current Assets | 180.09M | 266.45M | 424.82M | 565.81M | 726.43M | 749.71M |
| Property, Plant & Equipment | 20.57M | 24.55M | 37.10M | 47.06M | 53.33M | 57.90M |
| Other Long-Term Assets | 2.20M | 2.23M | 6.39M | 8.96M | 7.88M | 7.05M |
| Total Assets | 202.85M | 293.24M | 468.30M | 621.83M | 787.65M | 814.66M |
| Accounts Payable | 2.28M | 1.69M | 2.21M | 3.77M | 4.19M | 4.75M |
| Accrued Expenses | 9.18M | 22.97M | 35.88M | 35.59M | 33.33M | 35.65M |
| Short-Term Debt | 366.00K | |||||
| Current Portion of Leases | 9.21M | 9.06M | 8.75M | 8.46M | 8.06M | 7.79M |
| Current Unearned Revenue | 6.68M | 23.66M | 82.97M | 48.23M | 90.80M | |
| Other Current Liabilities | 3.72M | 28.74M | 54.55M | 47.14M | 560.00K | |
| Total Current Liabilities | 34.24M | 69.50M | 125.06M | 177.95M | 93.81M | 139.56M |
| Long-Term Debt | 9.32M | 9.39M | ||||
| Long-Term Leases | 13.70M | 17.49M | 24.38M | 30.46M | 35.27M | 39.81M |
| Long-Term Unearned Revenue | 162.87M | 164.54M | 172.17M | 210.84M | 443.37M | 334.42M |
| Other Long-Term Liabilities | 2.02M | 1.74M | 10.51M | 68.42M | 759.00K | 158.00K |
| Total Liabilities | 212.82M | 262.59M | 341.50M | 487.67M | 573.21M | 513.93M |
| Common Stock | 11.00K | 11.00K | 9.00K | 8.00K | 8.00K | 8.00K |
| Additional Paid-In Capital | 1.01B | 1.00B | 955.66M | 844.04M | 798.70M | 748.04M |
| Retained Earnings | -1.02B | -972.06M | -829.13M | -710.08M | -579.69M | -446.38M |
| Comprehensive Income & Other | -126.00K | 166.00K | 261.00K | 184.00K | -4.58M | -943.00K |
| Total Common Equity | -9.97M | 30.65M | 126.80M | 134.16M | 214.44M | 300.72M |
| Shareholders' Equity | -9.97M | 30.65M | 126.80M | 134.16M | 214.44M | 300.72M |
| Total Liabilities & Equity | 202.85M | 293.24M | 468.30M | 621.83M | 787.65M | 814.66M |
| Total Debt | 32.76M | 36.23M | 42.52M | 38.92M | 43.33M | 47.60M |
| Net Cash (Debt) | 140.04M | 219.79M | 370.88M | 509.94M | 669.52M | 687.65M |
| Net Cash Per Share | 1.29 | 2.13 | 3.84 | 6.09 | 8.12 | 8.55 |
| Filing Date Shares Outstanding | 111.66M | 110.36M | 99.09M | 95.75M | 83.03M | 82.04M |
| Total Common Shares Outstanding | 111.66M | 110.36M | 99.09M | 84.88M | 82.90M | 81.99M |
| Working Capital | 145.85M | 196.95M | 299.76M | 387.86M | 632.63M | 610.16M |
| Book Value Per Share | -0.09 | 0.28 | 1.28 | 1.58 | 2.59 | 3.67 |
| Tangible Book Value | -9.97M | 30.65M | 126.80M | 134.16M | 214.44M | 300.72M |
| Tangible Book Value Per Share | -0.09 | 0.28 | 1.28 | 1.58 | 2.59 | 3.67 |
| Machinery | 23.39M | 23.73M | 23.30M | 21.91M | 18.67M | |
| Leasehold Improvements | 24.94M | 26.36M | 26.62M | 26.23M | 25.95M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -117.85M | -142.93M | -119.05M | -130.39M | -133.31M | -36.33M |
| Depreciation & Amortization | 8.72M | 9.66M | 8.84M | 8.85M | 8.47M | 8.31M |
| Other Amortization | 312.00K | 293.00K | ||||
| Loss (Gain) From Sale of Assets | 48.00K | |||||
| Asset Writedown & Restructuring Costs | 1.77M | 2.92M | 2.21M | |||
| Loss (Gain) From Sale of Investments | -3.96M | -6.58M | -14.38M | -15.32M | -1.16M | 2.10M |
| Stock-Based Compensation | 16.76M | 26.66M | 39.46M | 42.80M | 46.15M | 40.78M |
| Change in Accounts Payable | 66.00K | -524.00K | -1.44M | -377.00K | -572.00K | 1.92M |
| Change in Unearned Revenue | -13.86M | -21.05M | -100.56M | -66.78M | 66.38M | 292.92M |
| Change in Other Net Operating Assets | -50.19M | -52.49M | -44.99M | -22.99M | -6.29M | -11.15M |
| Operating Cash Flow | -158.23M | -184.03M | -229.91M | -184.16M | -20.33M | 298.55M |
| Capital Expenditures | -160.00K | -41.00K | -1.25M | -2.38M | -4.12M | -3.25M |
| Investment in Securities | 153.37M | 196.64M | 108.39M | 104.30M | -154.90M | -46.42M |
| Investing Cash Flow | 153.21M | 196.60M | 107.13M | 101.92M | -159.01M | -49.66M |
| Long-Term Debt Issued | 9.39M | |||||
| Net Debt Issued (Repaid) | 9.39M | |||||
| Issuance of Common Stock | 20.17M | 20.21M | 72.15M | 2.55M | 4.51M | 30.30M |
| Financing Cash Flow | 20.17M | 20.21M | 81.54M | 2.55M | 4.51M | 30.30M |
| Net Cash Flow | 15.14M | 32.78M | -41.23M | -79.69M | -174.83M | 279.18M |
| Free Cash Flow | -158.39M | -184.07M | -231.16M | -186.54M | -24.45M | 295.30M |
| Free Cash Flow Margin | -1,142.55% | -874.66% | -229.88% | -192.19% | -18.30% | 142.60% |
| Free Cash Flow Per Share | -1.46 | -1.79 | -2.39 | -2.23 | -0.30 | 3.67 |
| Levered Free Cash Flow | -107.25M | -114.34M | -89.85M | 34.80M | -80.78M | 87.43M |
| Unlevered Free Cash Flow | -107.56M | -114.63M | -89.85M | 34.80M | -80.78M | 87.43M |
| Cash Interest Paid | 1.04M | 855.00K | ||||
| Change in Working Capital | -63.98M | -74.06M | -146.99M | -90.15M | 59.53M | 283.68M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 327.65M | 170.28M | 185.09M | 671.41M | 763.34M | 1.68B |
| Enterprise Value | 187.61M | -82.96M | -237.47M | 122.78M | 49.47M | 949.12M |
| Last Close Price | 2.21 | 1.56 | 1.89 | 7.98 | 9.23 | 20.65 |
| Forward PE | 27.71 | 27.71 | 27.71 | 27.71 | 11.75 | |
| PS Ratio | 23.63 | 8.09 | 1.84 | 6.92 | 5.71 | 8.11 |
| PB Ratio | 5.56 | 1.46 | 5.00 | 3.56 | 5.58 | |
| P/TBV Ratio | 5.56 | 1.46 | 5.00 | 3.56 | 5.58 | |
| P/FCF Ratio | 5.68 | |||||
| P/OCF Ratio | 5.62 | |||||
| EV/Sales Ratio | 13.53 | 1.26 | 0.37 | 4.58 | ||
| EV/FCF Ratio | 3.21 | |||||
| Debt / Equity Ratio | -3.29 | 1.18 | 0.34 | 0.29 | 0.20 | 0.16 |
| Debt / FCF Ratio | 0.16 | |||||
| Net Debt / Equity Ratio | 14.05 | -7.17 | -2.92 | -3.80 | -3.12 | -2.29 |
| Net Debt / EBITDA Ratio | 1.18 | 1.49 | 2.70 | 3.49 | 5.07 | 22.16 |
| Net Debt / FCF Ratio | 0.88 | 1.19 | 1.60 | 2.73 | 27.39 | -2.33 |
| Asset Turnover | 0.05 | 0.06 | 0.18 | 0.14 | 0.17 | 0.32 |
| Quick Ratio | 5.05 | 3.68 | 3.31 | 3.08 | 7.63 | 5.32 |
| Current Ratio | 5.26 | 3.83 | 3.40 | 3.18 | 7.74 | 5.37 |
| Return on Equity (ROE) | -385.11% | -181.56% | -91.24% | -74.81% | -51.75% | -12.79% |
| Return on Assets (ROA) | -27.62% | -25.13% | -16.37% | -13.46% | -10.75% | -3.58% |
| Return on Capital Employed (ROCE) | -73.30% | -68.40% | -41.60% | -34.20% | -19.90% | -5.50% |
| Earnings Yield | -49.15% | -83.94% | -64.32% | -19.42% | -17.46% | -2.17% |
| FCF Yield | -48.34% | -108.10% | -124.89% | -27.78% | -3.20% | 17.59% |
| Buyback Yield / Dilution | -9.71% | -6.64% | -15.35% | -1.54% | -2.55% | -3.42% |